| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |